# CVB Financial Corp: overview

CVBF · Nasdaq · CIK 354647 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvbf.md) · [Financials](/companies/cvbf/financials.md) · [Filings](/companies/cvbf/filings.md) · [Insiders](/companies/cvbf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.37](/filings/0001193125-25-272614.md) | not reported | [0.36](/filings/0001193125-26-214674.md) | [0.37](/filings/0001193125-26-340248.md) | [0.38](/filings/0001193125-25-272614.md) | not reported | [0.38](/filings/0001193125-26-214674.md) | [0.29](/filings/0001193125-26-340248.md) |
| Free cash flow | $m | [70.2 d](/filings/0001193125-25-272614.md) | [72.8 d](/filings/0001193125-26-083221.md) | [41.2](/filings/0001193125-26-214674.md) | [52.3 d](/filings/0001193125-26-340248.md) | [80.7 d](/filings/0001193125-25-272614.md) | [43.2 d](/filings/0001193125-26-083221.md) | [61.2](/filings/0001193125-26-214674.md) | [387 d](/filings/0001193125-26-340248.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.56](/filings/0000950170-24-022216.md) | [1.67](/filings/0000950170-25-029985.md) | [1.59](/filings/0001193125-26-083221.md) | [1.44](/filings/0001193125-26-083221.md) | [1.52](/filings/0001193125-26-083221.md) |
| Free cash flow | $m | [191](/filings/0000950170-24-022216.md) | [268](/filings/0000950170-25-029985.md) | [291](/filings/0001193125-26-083221.md) | [245](/filings/0001193125-26-083221.md) | [217](/filings/0001193125-26-083221.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cvbf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $579.3m | 25,688,910 |  | Added +6,662,367 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $236.9m | 10,506,193 |  | Added +2,549,968 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $229.0m | 10,155,075 |  | Added +2,264,677 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $226.7m | 10,051,580 |  | Added +2,438,293 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $221.8m | 9,834,715 |  | Added +2,393,864 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $170.3m | 7,550,510 |  | Added +1,861,852 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $143.9m | 6,380,873 |  | Added +1,782,821 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $101.0m | 4,476,687 |  | Added +1,194,937 |
| [Parallel Advisors, LLC](/funds/1690010.md) | 2026-06-30 | $79.6m | 3,529,148 |  | Reduced −129,205 |
| [HoldCo Asset Management, LP](/funds/1724246.md) | 2026-06-30 | $76.6m | 3,397,983 |  | Added +1,055,239 |

## Recent filings

[All 1,286 filings](/companies/cvbf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 10:01 ET | [8-K](/filings/0001193125-26-428238.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-428238 |
| 2026-08-07 | 20:10 ET | [10-Q](/filings/0001193125-26-340248.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340248 |
| 2026-07-23 | 10:10 ET | [8-K](/filings/0001193125-26-313203.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-313203 |
| 2026-07-23 | 10:05 ET | [8-K](/filings/0001193125-26-313195.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-313195 |
| 2026-06-15 | 20:05 ET | [8-K](/filings/0001193125-26-271066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-271066 |
| 2026-06-01 | 20:15 ET | [8-K](/filings/0001193125-26-251450.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-251450 |
| 2026-05-26 | 21:29 ET | [8-K](/filings/0001193125-26-239684.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-239684 |
| 2026-05-22 | 17:40 ET | [8-K](/filings/0001193125-26-236235.md) | 5.07 Shareholder vote results | 0001193125-26-236235 |
| 2026-05-08 | 20:16 ET | [10-Q](/filings/0001193125-26-214674.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214674 |
| 2026-05-07 | 21:01 ET | [8-K/A](/filings/0001193125-26-212352.md) | 9.01 Financial statements and exhibits | 0001193125-26-212352 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-083221.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 354647
- Tickers: CVBF
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: CA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.